Abstract
Intravitreal injection of interferon alpha-2b (IFN-α2b) is used to treat uveitis but its effect on the choroid is unknown. We histologically evaluated the choroidal changes after intravitreal injection of IFN-α2b. We compared histological samples of IFN-α2b-injected eyes to eyes with lipopolysaccharide (LPS)-induced uveitis and eyes injected with balanced salt solution (BSS) as controls. Rabbit eyes received intravitreal injections of BSS, IFN-α2b, or LPS, and enucleation was done seven days later. Choroidal changes were evaluated on histological cut sections. The thickness of the choroid was measured in micrometer and the severity of inflammation was scored. The mean maximum choroidal thickness was significantly greater in the IFN-α2b group in comparison to the LPS and BSS groups ( P < 0.001). The mean minimum choroidal thickness was also significantly greater in the IFN group compared to the BSS group ( P = 0.009). The observed changes were mainly due to vasodilation rather than interstitial fluid retention or inflammation. Mild inflammatory cell infiltration was observed in the choroid of four eyes in the IFN group and of three eyes in the LPS group. No inflammation was seen in the control group. The difference in inflammatory cell infiltration between the LPS and IFN groups was not statistically significant. Significant choroidal hyperemia was present after injection of IFN-α2b. This fact may suggest for some pharmacological applications of IFN-α2b when increased choroidal circulation is needed. However, further studies are required to elucidate the mechanisms involved.Impact statementType I interferons are proteins that are naturally secreted by cells in response to certain stimuli. They are approved for medical use to regulate immune responses in many disease states. Our findings of increased choroidal circulation after treatment of the eye with interferon alpha-2b indicate a possible effect of this cytokine on blood circulation. This is a novel finding that needs further investigation to elucidate mechanisms and applications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.